Navigation Links
Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
Date:2/12/2008

CORONA, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its New Drug Application (NDA) for silodosin, a novel alpha(1)- adrenoreceptor antagonist, has been accepted for filing by the U.S. Food and Drug Administration (FDA). Watson is seeking marketing approval of silodosin from the FDA for the treatment of the signs and symptoms associated with benign prostatic hyperplasia (BPH), or enlarged prostate. Watson anticipates that the FDA will take action on its application in the fourth quarter 2008.

Silodosin was designed to decrease urinary resistance and improve dysuria (difficulty or pain in urination) associated with BPH. In clinical trials, silodosin demonstrated a very low level of the most highly-reported cardiovascular and blood pressure-related side effects associated with existing BPH treatments, including dizziness and first-dose syncope (fainting).

"This filing highlights Watson's capabilities in new drug development and our commitment to this product, providing solutions to the millions of men with BPH symptoms," said Paul Bisaro, Watson's President and Chief Executive Officer. "Watson is expanding the portfolio it offers to urologists and their patients, focusing on symptom management that makes a big difference in their day-to-day lives."

Watson submitted the filing for silodosin with data from two Phase 3 multi-center (88 sites), randomized, double-blind, placebo-controlled trials that evaluated a total of 923 patients with signs and symptoms of BPH for 12 weeks. The trials demonstrated that a once daily 8mg dose of silodosin given for 12 weeks provided significant relief of BPH symptoms, compared with place
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
2. Watson Launches Generic Biaxin(R) XL
3. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
4. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
5. Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology
6. PTC Therapeutics Announces Publication of Preclinical Data in PNAS
7. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
8. TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
9. Inverseon Announces Positive Phase IIa Asthma Study
10. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
11. N30 Pharma Announces Successful Initiation of Human Studies With N30-201
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 2015 Researchers from University Hospitals Case Medical ... School of Medicine will present data from several new ... treatment for cancer patients with advanced solid tumors and ... lung cancer (SCLC), at the 51 st American ... Chicago . Jennifer ...
(Date:6/1/2015)... Telbec/ -  Ergoresearch Ltd (TSXV: ERG) – based in ... Équilibre, orthèses et biomécanique» banner  – announces its results ... dollar amounts in the present release are in Canadian currency. ... year 2015 ended this past March 31, 2015 totaled $ 3,299,994 decreasing ... the quarter ended March 31, 2014. This decrease can be ...
(Date:6/1/2015)... Women who took vitamin D and calcium supplements ... did not take the supplements, according to a study published ... of the European Menopause and Andropause Society. ... of the Women,s Health Initiative , one of the ... causes of death, disability and impaired quality of life in ...
Breaking Medicine Technology:UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 2UH Case Medical Center Experts to Present Data at 51st ASCO Annual Meeting 3Third Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended March 31, 2015 2Third Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended March 31, 2015 3Third Quarter results - Fiscal 2015 - Ergoresearch reports its results for the quarter ended March 31, 2015 4Vitamin D and Calcium Supplements Do Not Improve Menopausal Symptoms 2Vitamin D and Calcium Supplements Do Not Improve Menopausal Symptoms 3Vitamin D and Calcium Supplements Do Not Improve Menopausal Symptoms 4
... Ga., May 4, 2011 MiMedx Group, Inc. ... of patent protected biomaterial-based products and bioimplants processed ... of AmnioFix™ Nerve Wrap, the Company,s latest biologic ... for nerve repair. Produced from the ...
... 4, 2011 Plato BioPharma, Inc. (PBI) and Gilead ... at the "Novel Therapeutics in Pulmonary Fibrosis" session at ... Denver, Colorado on May 18, 2011.  The poster entitled ... Fibrosis and Lung Mechanics Following Bleomycin Instillation will ...
Cached Medicine Technology:MiMedx Announces Launch of AmnioFix™ Nerve Wrap 2Plato BioPharma Presenting Poster at the American Thoracic Society Conference 2
(Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... honors Lourinda Willey as a 2015-2016 ... Circle. She is recognized with this prestigious distinction for ... is the nation’s leading networking organization exclusively for professional ... operating Local Chapters. , "I’m pleased to present Lourinda ...
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... Kathy Everette-Gaines as a 2015-2016 inductee into its ... recognized with this prestigious distinction for leadership in ... exclusively for professional women, boasting more than 700,000 ... “I’m pleased to welcome Kathy into this exceptional ...
(Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... honors Lenita F. Cornett, DSL, LSSBB (C), ... Inductee into its VIP Woman of the Year Circle. ... in the military. NAPW is the nation's leading networking ... members and over 200 operating Local Chapters. , “I'm ...
(Date:6/1/2015)... Carson Energy also announced they have selected AdvantaIRA ... Trust, LLC is the country’s largest self-directed IRA administrator. ... using IRA’s does 2 things:, 1. It gives investors ... there current cash position will not allow for participation. ... and their investors to be able to participate in ...
(Date:6/1/2015)... New York (PRWEB) June 01, 2015 ... http://www.testosteronelawsuithub.com/ ) has amended the Case Management Order ... AndroGel testosterone gel. The Amended Order which was ... Illinois on May 29, 2015, directs the parties to ... by August 10, 2015 that outlines parameters and the ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Lourinda Willey, Owner and Principal of Lourinda R. Willey LLC, Into its VIP Professional Woman of the Year Circle 2Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lenita F. Cornett, First Sergeant of the US Military, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4
... Kong health authority had announced on Tuesday that the city ... HIV infections with 89 new cases reported// in the first ... Center for Health Protection under the Department of Health, which ... were related to sexual contact. Reviewing the AIDS situation in ...
... Shimla: The striking medicos, junior doctors and resident doctors ... College Tanda (Kangra),// took out a candle light procession ... central educational institutions. ,The striking medicos and doctors ... units of blood were collected and ran parallel OPDs. ...
... antidepressant Lexapro permitted by Food and Drug Administration, U.S.// ... FDA to sell escitalopram, a generic immitator of the oral ... drug are retained by the Forest Labs till March 2012 ... This copyright is illogical as per Teva. ,Lundbeck, ...
... that if the problem of people having HIV/AIDS as ... measures are not taken//. ,Launching the National ... the director general of Health Services said that the ... the population. "This is probably the reason TB is ...
... found that amino acid, l-cysteine can prevent oral cancers. ... cancers occur// in the mouth, pharynx and oesophagus. The ... results in a strong exposure of the upper digestive ... of Professor Mikko Salaspuro, University of Helsinki and Helsinki ...
... a recent study conducted by researchers at the Washington University ... States it was found// that regular exercise keeps Alzheimer’s at ... signs of the disease but now it is been disproved ... and found that balance problems and a weak handshake are ...
Cached Medicine News:Health News:Finnish research: Cysteine Chewing Gum as a cure for cancers of the mouth 2
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Quatroloc Revision Hip System...
Severe revision options for the knee and hip...
Severe revision options for the knee and hip...
Medicine Products: